Press Releases

Search Press Releases:

• All News
• 2017
• 2016
• 2015
• 2014
• 2013
• 2012
• 2011
• 2010

Tonix Pharmaceuticals to Present at the 2017 BIO International Convention

June 16, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals Participated in the "Pathophysiology of Posttraumatic Stress Disorder: Rethinking Drug Targets” Summit Sponsored by U.S. Department of Defense

June 15, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals to Present an Update of FDA Designated Breakthrough Therapy-TNX-102 SL for PTSD at the 2017 Marcum MicroCap Conference

June 12, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals Presented Retrospective Analyses of Treatment Response and Remission to TNX-102 SL in a Phase 2 Military-Related PTSD Study

May 30, 2017 • 4:30 PM EDT

Tonix Pharmaceuticals to Present Additional Clinical Results of Military-Related PTSD Study at the 2017 American Society of Clinical Psychopharmacology Annual Meeting

May 24, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals Presented Analyses of Potential Moderators of Treatment Response to U.S. FDA-Designated Breakthrough Therapy for PTSD, TNX-102 SL, in Phase 2 AtEase Study in Military-Related PTSD

May 22, 2017 • 4:05 PM EDT

Tonix Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Programs Update

May 15, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals to Present PTSD Clinical Data at the Society of Biological Psychiatry 72nd Annual Scientific Convention

May 11, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals Announces Issuance of U.S. Patent for TNX-102 SL Composition and Formulation: Designed for Transmucosal Absorption and Bedtime Daily Use

May 2, 2017 • 7:00 AM EDT

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Programs Update

April 17, 2017 • 7:00 AM EDT

• « Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• ...21
• Next »